Haemophilia is a genetic disorder that prevents blood from clotting, causing dangerous internal bleeding.

Haemophilia is a genetic disorder that prevents blood from clotting, causing dangerous internal bleeding.
Image: Intellect (generated)

In short: Haemophilia is an inherited condition that impairs the body's ability to form blood clots. While often associated with spontaneous joint and muscle bleeds, the severity varies significantly. Understanding how this genetic defect functions is essential for managing the condition and preventing long-term damage to joints and soft tissues.

Haemophilia is primarily an X-linked recessive genetic disorder, meaning it disproportionately affects males, while females typically act as carriers. The condition arises from a deficiency in specific clotting factor proteins: haemophilia A is caused by a lack of factor VIII, and haemophilia B is caused by a lack of factor IX. While most cases are inherited, about one-third of individuals with the condition develop it due to new genetic mutations.

The severity of the disorder is determined by the amount of clotting factor present in the blood. In severe cases, individuals may experience spontaneous bleeding into joints, muscles, or soft tissues, often appearing in early childhood. Moderate cases may involve bleeding after trauma, while mild forms might only manifest during surgery or dental procedures. If left untreated, internal bleeding into joints can lead to permanent damage, pain, and disfigurement.

Modern treatment focuses on replacing the missing clotting factors, often using recombinant, genetically engineered proteins. Patients with severe haemophilia may follow a prophylactic regimen, receiving regular injections to prevent bleeds before they occur, while others use on-demand treatment to stop bleeding episodes. Advances in medical care, including the use of implantable venous access devices, allow many patients to manage their condition at home, significantly improving their quality of life and ability to engage in everyday activities.

Diagnosis often involves blood tests to measure clotting factor levels, and genetic counseling is available for families with a history of the condition. While rare, some individuals develop antibodies known as inhibitors, which can render standard replacement therapies less effective, requiring specialized medical intervention. Ongoing monitoring by a dedicated haemophilia team is critical to review treatment progress, assess joint health, and address any complications that may arise.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-haemophilia.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…